Everpure Jumps 11.2% Premarket as S&P 500 Futures Slip 0.05%
Updated
Updated · Barron's · May 11
Everpure Jumps 11.2% Premarket as S&P 500 Futures Slip 0.05%
14 articles · Updated · Barron's · May 11
Everpure rose 11.2% in premarket trading, leading U.S. gainers, while Moderna added 8.3% ahead of the opening bell.
Moderna’s move extended earlier gains tied to investor focus on its hantavirus vaccine and treatment research after a reported U.S.-linked positive test.
Terex, Kodiak Gas Services and Intel each climbed at least 6%, while IREN and CareTrust REIT lagged with declines of 6.7% and 6.3%.
S&P 500 futures edged down 0.05% and Dow futures lost 0.12% even as Brent crude jumped 2.71%; the 10-year Treasury yield rose to 4.394%.
The mixed premarket setup followed Friday gains in the S&P 500 and Dow and came amid uneven trading in Asia and Europe.
A deadly virus outbreak makes a stock soar. Is this a flawed system or the future of medical innovation?
Moderna's vaccine shows promise against a killer virus. Is its mRNA platform the key to stopping future pandemics?
With human-to-human transmission confirmed, could the rare but deadly Andes virus become the next global health crisis?